These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7161613)

  • 1. Confusion, dementia and anticholinergics in Parkinson's disease.
    de Smet Y; Ruberg M; Serdaru M; Dubois B; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1161-4. PubMed ID: 7161613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental impairment in Parkinson's disease. The role of anticholinergic drugs.
    Meco G; Casacchia M; Lazzari R; Franzese A; Castellana F; Carta A; Iannuccelli M; Agnoli A
    Acta Psychiatr Belg; 1984; 84(4):325-35. PubMed ID: 6507124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal involuntary movements in relation to anticholinergics and levodopa therapy.
    Birket-Smith E
    Acta Neurol Scand; 1975 Aug; 52(2):158-60. PubMed ID: 1155032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.
    Kalisch Ellett LM; Pratt NL; Ramsay EN; Barratt JD; Roughead EE
    J Am Geriatr Soc; 2014 Oct; 62(10):1916-22. PubMed ID: 25284144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
    Horrocks PM; Vicary DJ; Rees JE; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):936-41. PubMed ID: 4772727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
    Cooper JA; Sagar HJ; Doherty SM; Jordan N; Tidswell P; Sullivan EV
    Brain; 1992 Dec; 115 ( Pt 6)():1701-25. PubMed ID: 1486457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic dementia in Parkinson disease treated by long-term administration of anticholinergic drug--evaluation of neuropsychological test, PET, and SPECT].
    Nishiyama K; Mizuno T; Sakuta M; Kurisaki H; Momose T
    Rinsho Shinkeigaku; 1991 Jun; 31(6):625-31. PubMed ID: 1934777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic therapy and dementia in patients with Parkinson's disease.
    Pondal M; Del Ser T; Bermejo F
    J Neurol; 1996 Jul; 243(7):543-6. PubMed ID: 8836945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden confusion with levodopa withdrawal.
    Lang AE
    Mov Disord; 1987; 2(3):223. PubMed ID: 3504551
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease.
    Levin BE; Llabre MM; Reisman S; Weiner WJ; Brown MC
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):412-6. PubMed ID: 1821262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piribedil: its synergistic effect in multidrug regimens for parkinsonism.
    Feigenson JS; Sweet RD; McDowell FH
    Neurology; 1976 May; 26(5):430-3. PubMed ID: 944394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective concept formation in parkinsonians is independent from mental deterioration.
    Caltagirone C; Carlesimo A; Nocentini U; Vicari S
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):334-7. PubMed ID: 2926416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiparkinsonian drugs].
    Rascol A; Montastruc JL; Rascol O
    Rev Prat; 1989 Mar; 39(8):663-9. PubMed ID: 2567051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug treatment of Parkinson's disease.
    Morris JG
    Aust Fam Physician; 1984 May; 13(5 Suppl):6-8, 11. PubMed ID: 6497767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of Parkinson's disease.
    Cohen MM; Scheife RT
    Am J Hosp Pharm; 1977 May; 34(5):531-8. PubMed ID: 326045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.
    Nishiyama K; Mizuno T; Sakuta M; Kurisaki H
    Adv Neurol; 1993; 60():479-83. PubMed ID: 8420174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overdose of anticholinergic agents and confusional syndrome].
    Choulot JJ; Mensire A; Saint Martin J
    Ann Pediatr (Paris); 1989 Dec; 36(10):714. PubMed ID: 2624388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroaminoacridine and the central anticholinergic syndrome.
    Hannington-Kiff JG
    Lancet; 1987 Apr; 1(8537):862. PubMed ID: 2882263
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced confusional states: the usual suspects?
    Hufschmidt A; Shabarin V; Zimmer T
    Acta Neurol Scand; 2009 Dec; 120(6):436-8. PubMed ID: 19804475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.